Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects

• Published in: Thrombosis and haemostasis Vol. 99; no. 5; p. 909
• Main Authors: Madden, Leigh A, Vince, Rebecca V, Sandström, Marie E, Taylor, Lee, McNaughton, Lars, Laden, Gerard
• Format: Journal Article
• Language: English
• Published: Germany 01.05.2008
• Subjects: Adolescent; Adult; Biomarkers - blood; Cardiovascular Diseases - blood; Cardiovascular Diseases - physiopathology; Cell Membrane Structures - metabolism; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Reference Values; Thromboplastin - metabolism; Vascular Cell Adhesion Molecule-1 - blood
• ISSN: 0340-6245
• DOI: 10.1160/TH08-01-0030

An increased risk of death or severe injury due to late-morning thrombotic events is well established. Tissue factor (TF) is the initiator of the coagulation cascade, and endothelial stresses, coupled with production of pro-coagulant microparticles (MP) are also important factors in loss of haemostasis. TF and vascular cell adhesion molecule-1 (VCAM-1) -positive cell microparticles were assessed periodically over a 24-hour (h) period in healthy human subjects to ascertain if they followed a circadian rhythm. Eleven healthy male subjects were assessed in a temperature-controlled environment with dietary intake consistent between subjects. Blood samples were taken every 4 h by venipuncture, and TF and VCAM-1 positive microparticles were quantified by flow cytometry. A significant circadian rhythm was observed in VCAM-1 MP (p=or<0.0001), and a trend was shown, although not statistically significant (p=0.065) in TF microparticles. A peak was observed at 9 a.m. for VCAM-1 positive MP, followed by a decrease and subsequent peak at 9 p.m. and a minimum at 5 a.m. TF-positive MP followed a strikingly similar trend in both variation and absolute numbers with a delay. A circadian rhythm was observed in VCAM-1 and less so TF-positive MP. This has significant implications in terms of the well known increased risk of cardiovascular thrombotic events matching this data. To our knowledge this is the first such report of quantified measurements of these MP over a 24-h period and the only measurement of a 24-h variation of in-vivo blood-borne TF.